• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 491/22 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or in which the condensed system contains four or more hetero rings

Patent holdings for IPC class C07D 491/22

Total number of patents in this class: 1062

10-year publication summary

45
43
46
47
59
60
85
98
132
94
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
296
25
Idemitsu Kosan Co., Ltd.
4237
21
Gilead Sciences, Inc.
2056
21
Merck Patent GmbH
5767
17
LG Chem, Ltd.
17676
13
Immunomedics, Inc.
260
12
Merck Sharp & Dohme LLC
3753
12
Nuvalent, Inc.
57
11
Promega Corporation
576
10
Hangzhou Adcoris Biopharma Co., Ltd.
18
10
Daiichi Sankyo Company, Limited
1877
9
ScinoPharm Taiwan, Ltd.
131
9
Abbvie Inc.
1806
8
Shanghai Hengrui Pharmaceutical Co., Ltd.
644
8
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
834
8
Shionogi & Co., Ltd.
844
8
Pinotbio, Inc.
43
8
Minghui Pharmaceutical (Hangzhou) Limited
33
7
Minghui Pharmaceutical (Shanghai) Limited
34
7
Duality Biologics (Suzhou) Co., Ltd.
44
7
Other owners 831